Showing results (1-10 of 371) with videos related to
Sort By:
Pageof 38
Science (New York, N.Y.)|January 15, 1971
Cyclic adenosine monophosphate and norepinephrine: effects on transmembrane properties of cerebellar Purkinje cellsG R Siggins, A P Oliver, B J Hoffer, et al.Science (New York, N.Y.)|February 9, 1973
Noradrenergic stimulation of cyclic adenosine monophosphate in rat Purkinje neurons: an immunocytochemical studyG R Siggins, E F Battenberg, B J Hoffer, et al.Journal of Cyclic Nucleotide Research|January 1, 1975
Characteristics of the release of adenosine 3':5'-monophosphate from micropipets by microiontophoresisW J Shoemaker, L T Balentine, G R Siggins, et al.Advances in Experimental Medicine and Biology|January 1, 1979
Neurotransmitters and neuromodulators and their mediation by cyclic nucleotidesG R SigginsDrug and Alcohol Dependence|May 1, 1979
Cyclic nucleotides in the development of alcohol tolerance and dependence: a commentaryG R SigginsScience (New York, N.Y.)|August 4, 1972
Adenosine 3',5'-monophosphate is localized in cerebellar neurons: immunofluorescence evidenceF E Bloom, B J Hoffer, E R Battenberg, et al.Drug and Alcohol Dependence|May 1, 1979
Central neurons are depressed by iontophoretic and micropressure application of ethanol and tetrahydropapaverolineG R Siggins, E FrenchNeuroscience Letters|April 9, 1981
Adenosine depression of hippocampal neurons in vitro: an intracellular study of dose-dependent actions on synaptic and membrane potentialsG R Siggins, P SchubertProceedings of the National Academy of Sciences of the United States of America|August 1, 1981
Morphine and opioid peptides reduce inhibitory synaptic potentials in hippocampal pyramidal cells in vitro without alteration of membrane potentialG R Siggins, W ZieglgänsbergerJournal of Neurophysiology|April 14, 1999
Somatostatin acts in CA1 and CA3 to reduce hippocampal epileptiform activityM K Tallent, G R SigginsPageof 38